Intrathecal Formulations
Intrathecal Formulations is a specialized category of parenteral formulations designed for direct delivery into the subarachnoid space of the spinal canal to achieve targeted central nervous system drug distribution with minimal systemic exposure.
75
Publications
4.3K
Citations
388
Authors
169
Institutions
Publications per year
2017–2026
11
Parents
75
1–5 of 75
388
3
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 388
169
University of California San Diego
San Diego, United States
6 h-index
16 publications
612 citations

University of Toronto
Toronto, Canada
3 h-index
7 publications
2.1K citations

Wake Forest University
Winston-Salem, United States
3 h-index
7 publications
467 citations
Atrium Health Wake Forest Baptist
Winston-Salem, United States
2 h-index
6 publications
354 citations
University of Colorado Boulder
Boulder, United States
2 h-index
9 publications
545 citations
Sunesis (United States)
South San Francisco, United States
2 h-index
4 publications
154 citations
Takeda (United States)
Deerfield, United States
2 h-index
11 publications
443 citations
Moffitt Cancer Center
Tampa, United States
2 h-index
32 publications
3.8K citations
1–8 of 169
8 publications · 258 citations
8
h-index
5 publications · 162 citations
5
h-index
3 publications · 63 citations
3
h-index
Repository · 3 publications · 52 citations
3
h-index
2 publications · 123 citations
2
h-index
1–5